TITLE

PASS NOTES: HRT--Part 2

AUTHOR(S)
Newson, Louise
PUB. DATE
September 2003
SOURCE
GP: General Practitioner;9/29/2003, p46
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Observational studies have reported that the risk of ischaemic heart disease may be reduced by up to 40 per cent in women taking hormone replacement therapy. However, there are differences between studies thought to be related to selection bias, so interpretation is extremely difficult. The Heart and Estrogen/Progestin Replacement study was the first randomised controlled trial of 2,763 postmenopausal American women with ischaemic heart disease. Data showed combined oestrogen and progestogen had no effect on myocardial infarction or coronary death after treatment for 4.1 years. One study looked at angiographic progression of existing coronary artery disease and found no effect of either oestrogen or combined oestrogen and progestogen over a three-year period. INSET: Summary points.
ACCESSION #
11121217

 

Related Articles

  • Lessons from HERS: The Null and Beyond. Bush, Trudy L. // Journal of Women's Health;Sep98, Vol. 7 Issue 7, p781 

    Last month, the results of Heart and Estrogen/Progestin Replacement Study (HERS), the first large, randomized, secondary prevention trial of hormone replacement therapy (HRT) to prevent heart disease were announced and published. The results were surprising: there was no overall cardiovascular...

  • Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study. Grodstein, Francine; Manon, JoAnn E.; Stampfer, Meir J. // Annals of Internal Medicine;7/3/2001, Vol. 135 Issue 1, p1 

    Discusses results of a study on the effectiveness of postmenopausal hormone use in the secondary prevention of coronary events. Patient characteristics; Decreasing recurrence of major coronary heart disease events with increasing duration of hormone use; Absence of difference between users of...

  • HRT does not prevent heart disease. Tanne, Janice Hopkins // BMJ: British Medical Journal (International Edition);8/16/2003, Vol. 327 Issue 7411, p359 

    Discusses how hormone replacement therapy (HRT) does not prevent coronary heart disease. Consideration of a medical trial that compared the combined estrogen and progestogen treatment with placebo; Risk of myocardial infarction and death in women who were given a placebo; Role of oestrogen in...

  • DOCUMENTED TRANSMURAL MYOCARDIAL INFARCTION IN A 21--YEAR--OLD WOMAN WITH NORMAL CORONARY ARTERIO GRAMS. Martin, Carroll M.; Kleid, Jack J. // Angiology;Jun1975, Vol. 26 Issue 6, p450 

    Examines the transmural myocardial infarction in a woman with normal coronary arteriograms. Association of oral contraceptives in acute myocardial infarction; Appearance of normal coronary arteries on arteriographic examination; Possibility of misinterpretation of the arteriograms.

  • POSTMENOPAUSAL HORMONE THERAPY AND CARDIOVASCULAR RISK. VandeKieft, Gregg // Journal of Family Practice;Nov1996, Vol. 43 Issue 5, p437 

    This article discusses research being done on the link between combination hormone replacement therapy (HRT) and the risk of cardiovascular disease. It references a study published in a 1996 issue of the "New England Journal of Medicine." Combined progestin and estrogen therapy has become the...

  • Hormone use and cardiovascular impact--age matters.  // Patient Care;Mar2006, Vol. 40 Issue 3, p9 

    Presents the results of studies on the link of postmenopausal hormone therapy (HT) to coronary heart disease. Benefits of early start of HT therapy on women who are near their menopausal period; Outcome of a Women's Health Initiative Study of combined estrogen and progestin therapy among...

  • MEDICINE IN THE NEWS. Kaplan, Deborah // Patient Care for the Nurse Practitioner;Mar2006, Vol. 9 Issue 3, p9 

    The article reports on a study which examined postmenopausal hormone therapy and the timing of its use. Discrepant findings between the Women's Health Initiative compared with observational studies of postmenopausal HT and coronary heart disease (CHD) led researchers to conduct the study. They...

  • What do we tell our patients now about HRT? Lockwood, Charles J. // Contemporary OB/GYN;Aug2002, Vol. 47 Issue 8, p8 

    Discusses the findings of several studies concerning the risks associated with hormone replacement therapy (HRT). Medical conditions associated with the use of estrogen and progestin therapy; Overview of studies contradicting the association between HRT and coronary heart disease; Notions about...

  • Which postmenopausal women should be offered combined HRT? Oliver, M. Norman; Sheufelt, Janice; Deshpande, Prajakta; Grandage, Karen K.; St. Anna, Leilani // Journal of Family Practice;Feb2003, Vol. 52 Issue 2, p149 

    The article talks about the adverse effects of hormone replacement therapy (HRT) on postmenopausal women including cardiovascular disease, thromboembolic disease and breast cancer. The Women's Health Initiative randomized trial of HRT on the use of estrogen plus progestin for prevention of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics